Sophia R Newcomer1, James Caringi2, Beth Jones1, Emily Coyle1,3, Timothy Schehl2, Matthew F Daley4,5. 1. 214607 School of Public and Community Health Sciences, University of Montana, Missoula, MT, USA. 2. 214607 School of Social Work, University of Montana, Missoula, MT, USA. 3. American Cancer Society, Montana Chapter, Missoula, MT, USA. 4. 535886 Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA. 5. Department of Pediatrics, School of Medicine, University of Colorado, Aurora, CO, USA.
Abstract
OBJECTIVES: Human papillomavirus (HPV) vaccination rates among adolescents are lower in rural areas than in urban areas of the United States. The objective of this study was to identify barriers to and facilitators of adolescent HPV vaccination in Montana, a large, primarily rural state. METHODS: Using a mixed-methods design, we integrated quantitative analyses of Montana's National Immunization Survey-Teen (NIS-Teen) data from 2013-2017 with qualitative data collected at a statewide meeting in October 2018 and from stakeholder interviews conducted from October 2018 through June 2019. Using NIS-Teen data, we identified trends and estimated adjusted prevalence ratios (aPRs) to identify factors associated with vaccine uptake. Using directed content analysis of qualitative data, we identified themes related to vaccine uptake. RESULTS: In Montana, initiation of the HPV vaccine series among adolescents aged 13-17 increased from 34.4% in 2013 to 65.5% in 2017. We identified 6 themes related to HPV vaccination from qualitative analyses, including medical providers' recommendation style as a facilitator of vaccination and parental vaccine hesitancy as a barrier to vaccination. In NIS-Teen 2017 data (n = 326 adolescents), receiving a medical provider recommendation was significantly associated with series initiation (aPR = 2.3; 95% CI, 1.5-3.6). Among parents who did not intend to initiate the vaccine series for their adolescent within 12 months (n = 71), vaccine safety was the top concern (aPR = 24.5%; 95% CI, 12.1%-36.9%). CONCLUSIONS: HPV vaccination rates have increased in Montana but remain lower than rates for other adolescent vaccines. Future work should focus on reducing missed opportunities, increasing parents' knowledge of and confidence in vaccination, and training medical providers on addressing common vaccine concerns.
OBJECTIVES:Human papillomavirus (HPV) vaccination rates among adolescents are lower in rural areas than in urban areas of the United States. The objective of this study was to identify barriers to and facilitators of adolescent HPV vaccination in Montana, a large, primarily rural state. METHODS: Using a mixed-methods design, we integrated quantitative analyses of Montana's National Immunization Survey-Teen (NIS-Teen) data from 2013-2017 with qualitative data collected at a statewide meeting in October 2018 and from stakeholder interviews conducted from October 2018 through June 2019. Using NIS-Teen data, we identified trends and estimated adjusted prevalence ratios (aPRs) to identify factors associated with vaccine uptake. Using directed content analysis of qualitative data, we identified themes related to vaccine uptake. RESULTS: In Montana, initiation of the HPV vaccine series among adolescents aged 13-17 increased from 34.4% in 2013 to 65.5% in 2017. We identified 6 themes related to HPV vaccination from qualitative analyses, including medical providers' recommendation style as a facilitator of vaccination and parental vaccine hesitancy as a barrier to vaccination. In NIS-Teen 2017 data (n = 326 adolescents), receiving a medical provider recommendation was significantly associated with series initiation (aPR = 2.3; 95% CI, 1.5-3.6). Among parents who did not intend to initiate the vaccine series for their adolescent within 12 months (n = 71), vaccine safety was the top concern (aPR = 24.5%; 95% CI, 12.1%-36.9%). CONCLUSIONS:HPV vaccination rates have increased in Montana but remain lower than rates for other adolescent vaccines. Future work should focus on reducing missed opportunities, increasing parents' knowledge of and confidence in vaccination, and training medical providers on addressing common vaccine concerns.
Authors: Peter G Szilagyi; Christina Albertin; Sharon G Humiston; Cynthia M Rand; Stanley Schaffer; Howard Brill; Joseph Stankaitis; Byung-Kwang Yoo; Aaron Blumkin; Shannon Stokley Journal: Acad Pediatr Date: 2013-01-09 Impact factor: 3.107
Authors: Paul L Reiter; Mary A Gerend; Melissa B Gilkey; Rebecca B Perkins; Debbie Saslow; Shannon Stokley; Jasmin A Tiro; Gregory D Zimet; Noel T Brewer Journal: Acad Pediatr Date: 2018-03 Impact factor: 3.107
Authors: Ingrid T Katz; Norma C Ware; Glenda Gray; Jessica E Haberer; Claude A Mellins; David R Bangsberg Journal: Sex Health Date: 2010-09 Impact factor: 2.706
Authors: Daniel A Salmon; Rupali J Limaye; Matthew Z Dudley; Oladeji K Oloko; Cathy Church-Balin; Mallory K Ellingson; Christine I Spina; Sarah E Brewer; Walter A Orenstein; Neal A Halsey; Allison T Chamberlain; Robert A Bednarczyk; Fauzia A Malik; Paula M Frew; Sean T O'Leary; Saad B Omer Journal: Vaccine Date: 2019-09-07 Impact factor: 3.641
Authors: Sameer Vali Gopalani; Amanda E Janitz; Margie Burkhart; Janis E Campbell; Sydney A Martinez; Ashley H White; Sixia Chen; Amber S Anderson; Stephanie F Pharr; Scott Patrick; Ashley Comiford Journal: Int J Environ Res Public Health Date: 2021-09-01 Impact factor: 4.614